Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations Meeting Abstract
| Authors: | Ho, A.; Brana, I.; Haddad, R.; Bauman, J.; Bible, K.; Faugeras, L.; Oosting, S.; Wong, D. J.; Ahn, M. J.; Boni, V.; Even, C.; Fayette, J.; Flor, M. J.; Harrington, K.; Kim, S. B.; Licitra, L.; Nixon, I.; Saba, N. F.; Sayehli, C.; Specenier, P.; Worden, F.; Balsara, B.; Britt, J.; Mishra, V.; Scholz, C.; Gualberto, A. |
| Abstract Title: | Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations |
| Meeting Title: | AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics |
| Journal Title: | Molecular Cancer Therapeutics |
| Volume: | 18 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2019 Oct 26-30 |
| Meeting Location: | Boston, MA |
| ISSN: | 1535-7163 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-12-01 |
| Language: | English |
| ACCESSION: | WOS:000510047200449 |
| DOI: | 10.1158/1535-7163.Targ-19-pr08 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PR08 -- Source: Wos |
